NO900474L - Bukspyttkjerteloeycelleantigener tilveiebragt ved molekylaer kloning. - Google Patents

Bukspyttkjerteloeycelleantigener tilveiebragt ved molekylaer kloning.

Info

Publication number
NO900474L
NO900474L NO90900474A NO900474A NO900474L NO 900474 L NO900474 L NO 900474L NO 90900474 A NO90900474 A NO 90900474A NO 900474 A NO900474 A NO 900474A NO 900474 L NO900474 L NO 900474L
Authority
NO
Norway
Prior art keywords
iddm
ica
cells
molecular cloning
pancreatic antigen
Prior art date
Application number
NO90900474A
Other languages
English (en)
Other versions
NO306996B1 (no
NO900474D0 (no
Inventor
Daniel Rabin
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of NO900474D0 publication Critical patent/NO900474D0/no
Publication of NO900474L publication Critical patent/NO900474L/no
Publication of NO306996B1 publication Critical patent/NO306996B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO900474A 1989-02-17 1990-02-01 Isolert bukspyttkjerteloey-celle-(ICA)-antigen for in vitro- bruk NO306996B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (3)

Publication Number Publication Date
NO900474D0 NO900474D0 (no) 1990-02-01
NO900474L true NO900474L (no) 1990-08-20
NO306996B1 NO306996B1 (no) 2000-01-24

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900474A NO306996B1 (no) 1989-02-17 1990-02-01 Isolert bukspyttkjerteloey-celle-(ICA)-antigen for in vitro- bruk

Country Status (14)

Country Link
EP (1) EP0383129B1 (no)
JP (1) JP2858467B2 (no)
AT (1) ATE122394T1 (no)
AU (1) AU626636B2 (no)
CA (1) CA2010275C (no)
DE (1) DE69019190T2 (no)
DK (1) DK0383129T3 (no)
ES (1) ES2072928T3 (no)
FI (1) FI103730B1 (no)
GR (1) GR3017019T3 (no)
IE (1) IE66997B1 (no)
IL (1) IL93397A (no)
NO (1) NO306996B1 (no)
PT (1) PT93166B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
ATE268908T1 (de) 1990-09-07 2004-06-15 Univ California Verfahren zur diagnose und behandlung von diabetes
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
AU8864791A (en) * 1990-10-02 1992-04-28 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
CA2103159A1 (en) * 1991-05-15 1992-11-16 Ake Lernmark Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
EP0627934A4 (en) * 1992-02-27 1997-01-08 Univ Leland Stanford Junior EARLY ANTIGEN FOR AUTOIMMUNE DIABETE.
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
JP2001527403A (ja) * 1997-04-25 2001-12-25 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE53862T1 (de) * 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
EP0229782B1 (en) * 1985-06-14 1992-11-04 Bristol-Myers Squibb Company Methods for identifying alleles associated with increased risk of diabetes
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
WO1988010120A1 (en) * 1987-06-24 1988-12-29 Brigham And Women's Hospital Treatment of autoimmune diseases by oral administration of autoantigens

Also Published As

Publication number Publication date
PT93166A (pt) 1990-08-31
PT93166B (pt) 1997-11-28
AU626636B2 (en) 1992-08-06
CA2010275A1 (en) 1990-08-17
FI900759A0 (fi) 1990-02-15
ES2072928T3 (es) 1995-08-01
EP0383129B1 (en) 1995-05-10
IE66997B1 (en) 1996-02-21
CA2010275C (en) 2000-08-29
FI103730B (fi) 1999-08-31
JP2858467B2 (ja) 1999-02-17
EP0383129A3 (en) 1991-07-31
DE69019190T2 (de) 1995-09-14
IL93397A (en) 1997-06-10
NO306996B1 (no) 2000-01-24
JPH0347133A (ja) 1991-02-28
EP0383129A2 (en) 1990-08-22
FI103730B1 (fi) 1999-08-31
NO900474D0 (no) 1990-02-01
ATE122394T1 (de) 1995-05-15
GR3017019T3 (en) 1995-11-30
DK0383129T3 (da) 1995-10-09
IE900589L (en) 1990-08-17
DE69019190D1 (de) 1995-06-14
AU4988390A (en) 1990-08-23
IL93397A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
NO900474L (no) Bukspyttkjerteloeycelleantigener tilveiebragt ved molekylaer kloning.
Pockley et al. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
WO2001053349A3 (en) Small cell lung cancer associated antigens and uses therefor
CA2029861A1 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
DE68925226T2 (de) Monoklonale Antikörper
DE59010925D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
ATE298798T1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE87487T1 (de) Rekombinante hiv-2 polypeptide.
DE3887750T2 (de) Selektive entfernung von immunkomplexen.
EP0293827A3 (en) Assay for leishmaniasis
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
WO2000020586A3 (en) Renal cancer associated antigens and uses therefor
AR011452A1 (es) Un polipeptido que comprende una porcion inmunogenica de un antigeno m.vaccae soluble aislado, o una variante del mismo, una molecula de adnaislada, un vector de expresion, una celula huesped, una proteina de fusion, una composicion farmaceutica que comprende dicho polipeptido, una vacuna, un
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)

Legal Events

Date Code Title Description
MK1K Patent expired